DE60211495D1 - Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms - Google Patents

Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms

Info

Publication number
DE60211495D1
DE60211495D1 DE60211495T DE60211495T DE60211495D1 DE 60211495 D1 DE60211495 D1 DE 60211495D1 DE 60211495 T DE60211495 T DE 60211495T DE 60211495 T DE60211495 T DE 60211495T DE 60211495 D1 DE60211495 D1 DE 60211495D1
Authority
DE
Germany
Prior art keywords
treatment
syndrome
reizdary
xanthine
glycol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60211495T
Other languages
English (en)
Other versions
DE60211495T2 (de
Inventor
E Huber
Wayne Mangel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE60211495D1 publication Critical patent/DE60211495D1/de
Application granted granted Critical
Publication of DE60211495T2 publication Critical patent/DE60211495T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60211495T 2001-02-28 2002-02-26 Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms Expired - Fee Related DE60211495T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27211501P 2001-02-28 2001-02-28
US272115P 2001-02-28
PCT/US2002/005973 WO2002067942A2 (en) 2001-02-28 2002-02-26 Methods of treating irritable bowel syndrome and functional dyspepsia

Publications (2)

Publication Number Publication Date
DE60211495D1 true DE60211495D1 (de) 2006-06-22
DE60211495T2 DE60211495T2 (de) 2006-12-14

Family

ID=23038466

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60211495T Expired - Fee Related DE60211495T2 (de) 2001-02-28 2002-02-26 Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms

Country Status (7)

Country Link
EP (1) EP1372661B1 (de)
JP (1) JP2004523559A (de)
AT (1) ATE326225T1 (de)
AU (1) AU2002252134A1 (de)
DE (1) DE60211495T2 (de)
ES (1) ES2262798T3 (de)
WO (1) WO2002067942A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1521584A1 (de) 2002-06-17 2005-04-13 Glaxo Group Limited Purin-derivate als leber x-rezeptor-agonisten
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20090208456A1 (en) 2004-07-27 2009-08-20 Gilead Sciences, Inc. Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
EP2527360B1 (de) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017577A (en) * 1986-04-25 1991-05-21 Burroughs Wellcome Co. Methods for treating viral infection
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
WO1999043673A1 (fr) * 1998-02-26 1999-09-02 Zenyaku Kogyo Kabushiki Kaisha Derives de 1-aza-indolizine
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
WO2002067942A2 (en) 2002-09-06
AU2002252134A1 (en) 2002-09-12
JP2004523559A (ja) 2004-08-05
ATE326225T1 (de) 2006-06-15
DE60211495T2 (de) 2006-12-14
EP1372661B1 (de) 2006-05-17
ES2262798T3 (es) 2006-12-01
EP1372661A2 (de) 2004-01-02
WO2002067942A3 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
DE60122767D1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
MXPA02011425A (es) Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa.
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
ATE451921T1 (de) Phenylindole zur behandlung von hiv
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ES2177316T3 (es) Anticuerpos humanos antifacotores ix/ixa.
SE0302304D0 (sv) Novel compounds
DE60211495D1 (de) Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms
ATE363474T1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
ATE410235T1 (de) Behandlung von ballastwasser
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
CY1106409T1 (el) Παραγωγα κινολινης

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee